Locations:
Search IconSearch
April 4, 2022/Neurosciences/Podcast

Epilepsy Surgery: An Underused Treatment Option (Podcast)

Surgery can be a game changer when medications fail to control seizures

Epilepsy surgery is a viable treatment option when more than two appropriately prescribed medications fail to control seizures. However, it remains significantly underutilized.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Every patient is a surgical candidate once they fail a couple of medicines,” says William Bingaman, MD, Vice Chair of Cleveland Clinic’s Neurological Institute and Director of the Epilepsy Surgery Program in its Charles Shor Epilepsy Center. “The trick then is just to be able to tell patients what their chances are to become seizure free so they can drive, work or even just take a bath or shower by themselves without fear of drowning.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Bingaman discusses the state of epilepsy surgery and its value in the care of individuals with uncontrolled epilepsy. He touches on:

  • The evolution of epilepsy surgery
  • Factors that contribute to low surgical referrals
  • Types of epilepsy procedures, including resection, palliative surgery and laser ablation
  • The role of magnetoencephalography and imaging modalities
  • The future of epilepsy surgery and drug delivery into the brain

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: The great news is that there are a lot of epilepsy drugs out there now, versus when you and I started to practice. In some ways, the bad news is that there are a lot of epilepsy drugs out there. It becomes easy for neurologists to say, “Well, let’s try this new drug,” doesn’t it?

Advertisement

Dr. Bingaman: It could take 10 or 15 years probably to go through all the drugs on a fair trial. It reminds me of a patient I saw last year who came up from central Ohio. She was in her late 60s, and she had hippocampal sclerosis, the most common adult epilepsy we see and also the type that responds most successfully to epilepsy surgery. She had a febrile convulsion as a baby. At 15, she started having seizures and had been seizing for 50 years.

She and her husband were sitting in my clinic and we were talking about temporal lobectomy, which we typically don’t do on people in their 60s. Occasionally we do, but it’s rare. So I said, “Gosh, you’ve had seizures for 50-some years. Why now? Why are you here now?” And she looked at me and said, “Well, I didn’t know surgery was an option.” … That’s unfortunately something we still see, and 50 years of uncontrolled epilepsy can really do a number on someone.

Advertisement

Related Articles

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular

Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy

MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular

Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Ad